Detailled Information

Name of the Instrument/Tool Primary Sjögren’s Syndrome Quality of Life (PSS-QoL)
First Description

Lackner A, Stradner MH, Hermann J, et al. Assessing health-related quality of life in primary Sjögren's syndrome-The PSS-QoL. Semin Arthritis Rheum. 2018;48(1):105-110. doi:10.1016/j.semarthrit.2017.11.007

Year 2018
Domains
Concept of constructs Health related quality of life
Population/Disease Disease specific
Originally developed for Sjögren's syndrome
Other rheumatic diseases
where can be applied (only if validated)
---
Additional population with no rheumatic diseases No
Language: Originally published in English
Available in Language German
REFERENCE IDENTIFICATION
Author/s Lackner A, Stradner MH, Hermann J, et al.
Title Assessing health-related quality of life in primary Sjögren's syndrome-The PSS-QoL.
Journal Semin Arthritis Rheum
Year 2018
Vol 48
Num 1
Pages 105-110
Country Austria
Language German
Other references of interest
Link https://pubmed.ncbi.nlm.nih.gov/21345815/
Brief Description

Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, et al. EULAR Sjogren’s Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren’s syndrome. Ann Rheum Dis 2011;70:968–72. doi:10.1136/ard.2010.143743.

Link https://link.springer.com/article/10.1007/s00296-014-3008-0
Brief Description

Kotsis K, Voulgari P V., Tsifetaki N, Drosos AA, Carvalho AF, Hyphantis T. Illness perceptions and psychological distress associated with physical healthrelated quality of life in primary Sjögren’s syndrome compared to systemic lupus erythematosus and rheumatoid arthritis. Rheumatol Int 2014;34:1671– 81. doi:10.1007/s00296-014-3008-0.

Link https://pubmed.ncbi.nlm.nih.gov/27390310/
Brief Description

Cornec D, Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot J-M, Perdriger A, et al. Severe Health-Related Quality-of-life Impairment in Active Primary Sjögren’s Syndrome Is Driven by Patient-Reported Outcomes: Data from a Large Therapeutic Trial. Arthritis Care Res (Hoboken) 2016. doi:10.1002/acr.22974.

Instrument/Tool Translations References
No other References.
DEVELOPER CONTACT INFORMATION
Correspondence to Angelika Lackner, PhD
E-Mail angelika.lackner@medunigraz.at
Address Auenbruggerplatz 15, 8036 Graz, Austria
Website ---
Available ---
Links ---
DESCRIPTION OF THE INSTRUMENT
Type Of Measure Questionnaire
Brief Description

The PSS-QoL is the first instrument for the evaluation of HRQL in PSS patients. The final version for testing of the PSS-QoL consisted of 25 questions in German language. Subsequently, an English Version of the PSS-QoL was developed. It is divided into a physical and psychosocial dimension, and all questions pertain to patients’ experiences within the last four weeks. PSS-QoL can be divided in the following domains: total score, physical, discomfort, dryness, psychosocial.

Number of Items ---
Range The PSS-QoL ranges from 0 to 96 (for women) and from 0 to 92 (for men, excluding vaginal dryness).
Responses options/scale Yes
ranging from 0 to 10; 5-point- Likert scale (0-4)
Developed for Clinical practice, Research
PRACTICAL APPLICATION
Method of administration Self-administered
Recommendations to score

The physical dimension consists of a numeric rating scale (NRS, ranging from 0 to 10) for discomfort and checkboxes for each physical symptom considered to impair HRQL. Symptom related questions can be answered by using checkboxes meaning “yes” if marked. Each “yes” adds 1 point to the score. The psychosocial dimension can be scored on a 5-point- Likert scale and contains 14 questions/statements with the following possible answers: never, rarely, sometimes, often and always. These questions can be scored 0 (=never) to 4 (=always).

Score Interpretation Higher scores indicate worse quality of life
Cut-off points ---
Cut-off points applied to ---
Smallest detectable change if described ---
Smallest detectable change applied to ---
Completion time by the patient 4 minutes
Scoring time by the assessor - minutes
Training to score Not necessary
Strengths Easy to use, Useful in clinical practice & research
Limitations Not widely used
OTHER COMMENTS
Other Comments ---